Genomic Characterization of Papillary Thyroid Cancer Reveals Germline Mutations Associated With Congenital Hypothyroidism

PURPOSEThyroid dyshormonogenesis, a form of congenital hypothyroidism, is characterized by defects in thyroid hormone synthesis genes, affecting both children and adults. However, the potential link between such genetic defects and the development of papillary thyroid cancer (PTC) remains unclear.ME...

書誌詳細
出版年:	JCO Global Oncology
主要な著者:	Vaishakhi Trivedi, Hitesh Kore, Disha Poojary, Vanita Noronha, Munita Bal, Pratik Chandrani, Anuradha Choughule, Priyanka Pange, Vinod Gupta, Nandini Menon, Vijay Patil, Minit Shah, Pankaj Chaturvedi, Kumar Prabhash, Amit Dutt
フォーマット:	論文
言語:	英語
出版事項:	American Society of Clinical Oncology 2025-05-01
オンライン･アクセス:	https://ascopubs.org/doi/10.1200/GO-25-00043

類似資料

Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in THRA, a Potential Modifier of Cellular Plasticity
著者:: Vaishakhi Trivedi, 等
出版事項: (2025-07-01)

Association of Cutibacterium acnes with human thyroid cancer
著者:: Vaishakhi Trivedi, 等
出版事項: (2023-11-01)

Identification of EGFR mutations in type II papillary renal cell carcinoma
著者:: Prerana Jha, 等
出版事項: (2023-01-01)

Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation
著者:: Asim Joshi, 等
出版事項: (2022-08-01)

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer
著者:: Vichitra Behel, 等
出版事項: (2022-07-01)

NUT-midline carcinoma of the lung with rare BRD3-NUTM1 fusion
著者:: Prerana Jha, 等
出版事項: (2024-01-01)

Assessment of plasma derived microbiome profiles in lung cancer using targeted and whole exome sequencing
著者:: Vichitra Behel, 等
出版事項: (2025-06-01)

Authors' reply to Maskomani
著者:: Minit Shah, 等
出版事項: (2023-01-01)

Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy
著者:: Jaspreet Kaur, 等
出版事項: (2023-01-01)

NRAS mutation in differentiated thyroid cancer
著者:: Saswata Saha, 等
出版事項: (2022-01-01)

The Impact of Baseline Vitamin D Level in Patients Receiving Gefitinib-Directed Therapy for EGFR-Mutant Non–Small-Cell Lung Cancer
著者:: Vanita Noronha, 等
出版事項: (2024-05-01)

Molecular tumor board: Case 1-Interplay of EGFR, MET and PD-L1 in non-small cell lung carcinoma
著者:: Akhil Kapoor, 等
出版事項: (2019-01-01)

Authors' reply to Batra et al., Chadha et al., and Deb et al.
著者:: Akhil Kapoor, 等
出版事項: (2020-01-01)

Authors' reply to Dubey et al. and Bhattacharyya et al.
著者:: Akhil Kapoor, 等
出版事項: (2020-01-01)

Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.
著者:: Anuradha Chougule, 等
出版事項: (2013-01-01)

Authors' reply to Krishnamurthy et al.
著者:: Goutam Santosh Panda, 等
出版事項: (2022-01-01)

Cabozantinib: A narrative drug review
著者:: Vivek K Srigadha, 等
出版事項: (2023-01-01)

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
著者:: Vanita Noronha, 等
出版事項: (2020-01-01)

Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trial
著者:: Vanita Noronha, 等
出版事項: (2025-07-01)

Amivantamab: A narrative drug review
著者:: Anupa John, 等
出版事項: (2023-01-01)

Authors' reply to Shah and Sahu
著者:: Anupa John, 等
出版事項: (2023-01-01)

Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India
著者:: Atul Tiwari, 等

Bendamustine in the third line or beyond in metastatic, recurrent, or relapsed head-and-neck cancers: A retrospective observational study
著者:: Vijay Patil, 等
出版事項: (2022-01-01)

Authors' reply to Chandrasekharan et al. and Abbas
著者:: Akhil Kapoor, 等
出版事項: (2020-01-01)

Paclitaxel with Mycidac-C in the second line and beyond in advanced head-and-neck cancer: A retrospective analysis from a tertiary cancer center
著者:: Rup J Sarma, 等
出版事項: (2022-01-01)

Leptomeningeal metastasis from extracranial solid tumors
著者:: Dilip Harindran Vallathol, 等
出版事項: (2020-01-01)

Authors' reply to Dhanushkodi et al. and Chalissery
著者:: Gunjesh Kumar Singh, 等
出版事項: (2020-01-01)

Vaccination practices, efficacy, and safety in adults with cancer: A narrative review
著者:: Laboni Sarkar, 等
出版事項: (2021-01-01)

Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience
著者:: Prerana Jha, 等
出版事項: (2025-06-01)

Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics
著者:: Anuradha Chougule, 等
出版事項: (2022-05-01)

Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs
著者:: Ashwin Butle, 等
出版事項: (2021-08-01)

Authors' reply to Nandi
著者:: Jaspreet Kaur, 等
出版事項: (2023-01-01)

Genetic counselling in India: The state of affairs
著者:: Minit Shah, 等
出版事項: (2023-01-01)

Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
著者:: Poonam Joshi, 等
出版事項: (2015-01-01)

The masquerader
著者:: Abhishek Mahajan, 等
出版事項: (2022-01-01)

Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience
著者:: Vanita Noronha, 等
出版事項: (2020-07-01)

Translation and Validation of COST - FACIT (Version 2) Questionnaire into Hindi and Marathi to Assess Financial Toxicity in Indian Cancer Patients
著者:: Amit Joshi, 等
出版事項: (2022-04-01)

Palliative oral triple metronomic chemotherapy in a patient with head-and-neck cancer during the COVID-19 pandemic in India: A case report
著者:: Sachin Babanrao Dhumal, 等
出版事項: (2020-01-01)

Understanding the Impact of Population and Cancer Type on Tumor Mutation Burden Scores: A Comprehensive Whole-Exome Study in Cancer Patients From India
著者:: Nishtha AjitSingh Tanwar, 等
出版事項: (2023-09-01)

Immunoglobulin G4-related disease (IgG4-RD) manifestations in the head-and-neck: A narrative review with a focus on imaging
著者:: Shreya Shukla, 等
出版事項: (2023-01-01)